LB PHARMACEUTICALS INC (LBRX) › Cash & EquivalentsLB PHARMACEUTICALS INC (LBRX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $22.98M2025: $250.17M$250.17M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$250.17M+988.8%2024$22.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share